Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips

　　1.Approved Indications

　　Azacitidine,a nucleoside metabolic inhibitor,is prescribed for:

　　1.Intermediate-to High-Risk MDS:Improves blood cell counts,reduces leukemia progression risk.

　　2.AML(especially elderly patients or ineligible for intensive chemotherapy):Prolongs survival and enhances quality of life.

　　3.CMML:Controls disease progression and symptomatic relief.

　　2.Cross-Border Purchase Options

　　1.Local Healthcare Facilities:Injectable formulations available in mainland China hospitals under medical supervision.

　　2.Hong Kong Purchase Options:

　　○Approved tablets(200mg×7 tablets)are available in Hong Kong hospitals/pharmacies,priced at tens of thousands HKD.Ensure compliance with import regulations.

　　3.Overseas Sources:Obtain tablets through accredited international pharmacies or medical centers,prioritizing legitimacy.

　　3.Essential Precautions

　　1.Prescription-Only Medication:Requires hematologist/oncologist supervision.

　　2.Baseline Assessments:Mandatory blood tests,liver/renal function evaluations before initiation.

　　3.Monitoring&Safety Measures:

　　○Regular blood count monitoring due to risk of myelosuppression(anemia,increased infection susceptibility).

　　○Manage common side effects(nausea,vomiting,diarrhea,fatigue)promptly.

　　4.Contraindications:Prohibited during pregnancy/breastfeeding;use with caution in hepatic/renal impairment cases.

　　4.Generic Availability Status

　　Original branded formulation only;no generics currently approved.Patients should prioritize reliable supply chains based on affordability.